less in-vitro activity was demonstrated cefotaxime ( 91 % susceptible to 16 mg/l , p = 0.07 ) , latamoxef ( moxalactam ) ( 90 % , p = 0.04 ) , cefoperazone ( 90 % , p = 0.04 ) , ceftriaxone ( 87 % , p = 0.008 ) , cefmenoxime ( 80 % , p = 0.0001 ) , and ceftizoxime ( 79 % , p less than 0.0001 ) .
C0007554
cefotaxime
C0007560
ceftizoxime